Literature DB >> 28382500

Impact of esophageal flexion level on the surgical outcome in patients with sigmoid esophageal achalasia.

Kazuto Tsuboi1, Nobuo Omura2, Fumiaki Yano2, Masato Hoshino2, Se-Ryung Yamamoto2, Shunsuke Akimoto2, Takahiro Masuda2, Hideyuki Kashiwagi2, Katsuhiko Yanaga2.   

Abstract

PURPOSE: Esophageal achalasia can be roughly divided into non-sigmoid and sigmoid types. Laparoscopic surgery has been reported to be less than optimally effective for sigmoid type. The aim of this study was to examine the impact of the esophageal flexion level on the clinical condition and surgical outcomes of patients with sigmoid esophageal achalasia.
METHODS: The subjects were 36 patients with sigmoid esophageal achalasia who had been observed for >1 year after surgery. The subjects were divided into sigmoid type (Sg) and advanced sigmoid type (aSg) groups based on the flexion level of the lower esophagus to compare their clinical parameters and surgical outcomes.
RESULTS: The Sg and aSg groups included 26 (72%) and 10 subjects, respectively. There were no marked differences in the clinical parameters or surgical outcomes between the two groups. However, the clearance rate calculated using the timed barium esophagogram was lower in the aSg group than in the Sg group. No differences were found in the postoperative symptom scores between the two groups, and both reported a high level of satisfaction.
CONCLUSIONS: Although laparoscopic surgery for symptoms of sigmoid esophageal achalasia was highly successful regardless of the flexion level, the improvement in esophageal clearance was lower when the flexion level was higher.

Entities:  

Keywords:  Esophageal achalasia; Flexion level; Sigmoid type; Surgical outcome

Mesh:

Year:  2017        PMID: 28382500     DOI: 10.1007/s00595-017-1519-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  30 in total

1.  Laparoscopic Heller myotomy and fundoplication in patients with end-stage achalasia.

Authors:  Fernando A M Herbella; Marco G Patti
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

Review 2.  Epidemiology and demographics of achalasia.

Authors:  J F Mayberry
Journal:  Gastrointest Endosc Clin N Am       Date:  2001-04

3.  Hospitalization for achalasia in the United States 1997-2006.

Authors:  Amnon Sonnenberg
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

4.  Long-term outcome of Heller myotomy in achalasic sigmoid esophagus.

Authors:  Tommaso Claudio Mineo; Eugenio Pompeo
Journal:  J Thorac Cardiovasc Surg       Date:  2004-09       Impact factor: 5.209

5.  Factors associated with rapid progression to esophagectomy for benign disease.

Authors:  Arin L Madenci; Bradley N Reames; Andrew C Chang; Jules Lin; Mark B Orringer; Rishindra M Reddy
Journal:  J Am Coll Surg       Date:  2013-09-11       Impact factor: 6.113

6.  Improving the surgery for sigmoid achalasia: long-term results of a technical detail.

Authors:  Enrico Faccani; Sandro Mattioli; Maria Luisa Lugaresi; Massimo Pierluigi Di Simone; Tommaso Bartalena; Vladimiro Pilotti
Journal:  Eur J Cardiothorac Surg       Date:  2007-10-10       Impact factor: 4.191

7.  The risk of esophageal cancer in patients with achalasia. A population-based study.

Authors:  R S Sandler; O Nyrén; A Ekbom; G M Eisen; J Yuen; S Josefsson
Journal:  JAMA       Date:  1995-11-01       Impact factor: 56.272

8.  Timed barium esophagram in achalasia types.

Authors:  A Zanoni; T W Rice; R Lopez; S Birgisson; S S Shay; P N Thota; M E Baker; D P Raymond; E H Blackstone
Journal:  Dis Esophagus       Date:  2014-03-20       Impact factor: 3.429

Review 9.  The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

Authors:  Peter J Kahrilas; Guy Boeckxstaens
Journal:  Gastroenterology       Date:  2013-08-21       Impact factor: 22.682

Review 10.  Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes.

Authors:  Orla M O'Neill; Brian T Johnston; Helen G Coleman
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.